スポンサーリンク
Nagoya Medical Center Nagoya Jpn | 論文
- Possible Attenuation of Fas-Mediated Signaling by Dominant Expression of Caspase-8 Aberrant Isoform in Adult T-Cell Leukemia Cells
- A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
- Immunohistochemical and Immunogenetic Analyses of Ocular Adnexal Lymphoid Proliferation
- Clinical Effects of Infusing Anti-Epstein -Barr Virus (EBV)-Specific Cytotoxic T-Lymphocytes into Patients with Severe Chronic Active EBV Infection
- Comparison of Soluble and Membrane Bound HLA-Class I and DR Levels in Umbilical Cord Blood and Adult Peripheral Blood
- The Generation of Immunocompetent Dendritic Cells From CD34^+ Acute Myeloid or Lymphoid Leukemia Cells
- Autografting with peripheral blood CD34-positive cells following high-dose chemotherapy against breast cancer
- Bernard-Soulier Syndrome due to GPIX W127X Mutation in Japan Is Frequently Misdiagnosed as Idiopathic Thrombocytopenic Purpura
- Permanent Loss of Vision Following Cosmetic Rhinoplastic Surgery
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- In Vitro Effects of Recombinant Human IL-11 on Human Malignant Lymphoma Cells
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement : The Nagasaki Transplant Group experience
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95